Nirvana are developing naturally sourced psychedelics in novel formulations to provide non-addictive solutions that are effective in managing pain and addiction. They are hoping to use compounds derived from psilocybin and ibogaine to help people manage pain and treat opioid addiction more effectively.
Nirvana
From the website: “Nirvana Life Sciences has been founded with a simple objective of developing non-addictive pain management products that can provide healthier outcomes for patients who live with chronic pain.”
News
- Endocan Announces Amendment to Agreement to Acquire Nirvana Life Sciences Inc. (Yahoo Finance, August 2021)
Activities
B2B
B2C
Drug Discovery
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates